REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$654.27
Tradestie Score
63
Market Cap
$63.59B
P/E Ratio
15.2
Revenue Growth
0.2%
Analyst Upside
+27.4%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$528.04
|
$103.64B | 29.6 | 59 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$312.78
|
$60.38B | 75.8 | 64 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$939.68
|
$46.96B | 41.7 | 62 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$297.65
|
$36.81B | 65.8 | 59 | Compare |
|
INSM
Insmed, Inc.
|
$111.60
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$97.55
|
$24.57B | - | 56 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$216.12
|
$22.61B | 22.6 | 67 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.52
|
$19.56B | 20.9 | 63 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.86
|
$16.93B | 16.1 | 61 | Compare |
|
ILMN
Illumina Inc
|
$188.68
|
$15.72B | 33.4 | 59 | Compare |
More REGN Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry